Bernard Massie

This inventor holds 17 USPTO granted patents, plus 10 CIPO patents and 4 EPO patents, primarily in Gene Expression Regulation. Top assignees: National Research Council of Canada, Centre De Recherche Du Centre Hospitalier De L'université De Montréal, Other. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard Massie. Retrieved from https://idiyas.com/inventor/bernard-massie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 70.6

CIPO Patents = 10

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 140(Granted Patents)

Location History:

Laval, CA (1996 - 2018)
Montreal, CA (2003 - 2020)

Company Filing History:

13 out of 1,039

National Research Council of Canada

patents

1 out of 1

Centre De Recherche Du Centre Hospitalier De L'université De Montréal

patent

3 out of 834,570

Other

patents

Years Active: 1996-2020

Loading Chart...

Areas of Expertise:

Gene Expression

Adenoviral Vectors

Recombinant Proteins

Insulin-like Growth Factor

Antibodies

Inducible Systems

Cell Lines

Protein Production

Eukaryotic Expression

Recombinant Protein Expression

CymR

Herpes Simplex Virus

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10538575 - Soluble IGF receptor Fc fusion proteins and uses thereof (2020-01-21),

2. 10112998 - Insulin-like growth factor 1 receptor-specific antibodies and uses thereof (2018-10-30),

3. 10106614 - Insulin-like growth factor 1 receptor-specific antibodies and uses thereof (2018-10-23),

4. 10100117 - Insulin-like growth factor 1 receptor-specific antibodies and uses thereof (2018-10-16),

5. 9217020 - Constructs for enhancement of gene expression in muscle (2015-12-22),

6. 8728759 - Reverse cumate repressor mutant (2014-05-20),

7. 8318455 - Inducible/regulated gene expression system in E coli (2012-11-27),

8. 8216821 - Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria (2012-07-10),

9. 8163894 - DNA for eukaryotic expression of CymR (2012-04-24),

10. 7745592 - Cumate-inducible expression system for eukaryotic cells (2010-06-29),

11. 6642052 - Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease (2003-11-04),

12. 6620618 - Complementary cell line for the growth of adenovirus mutants with a deleted protease gene (2003-09-16),

13. 6524821 - Anti-apoptotic compositions comprising the R1 subunit of herpes simplex virus ribonucleotide reductase or its N-terminal portion; and uses thereof (2003-02-25),

14. 6291226 - Adenovirus mutants with deleted protease gene (2001-09-18),

15. 6210922 - Serum free production of recombinant proteins and adenoviral vectors (2001-04-03),

Title: Bernard Massie - Innovative Inventor from Laval, CA

Introduction: Bernard Massie is a renowned inventor hailing from Laval, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Bernard Massie holds several patents in various technological domains, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: Throughout his illustrious career, Bernard Massie has been instrumental in developing cutting-edge technologies that have revolutionized industries and improved the lives of many.

Collaborations: Bernard Massie has collaborated with leading tech companies, research institutions, and universities to further his innovative projects and bring his ideas to fruition.

Conclusion: Bernard Massie's passion for innovation and his relentless drive to create have solidified his position as a pioneering inventor in the technological landscape.

Profile summary based on public USPTO records.